AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like Arbutus' LNP Licensee Alnylam Initiates Rolling Submission of NDA to U.S. FDA for Patisiran November 16, 2017 Achillion Slashes Staff and Initiates Restructuring Following Termination of J&J Deal February 21, 2018 Hill-Rom To Host Fiscal Fourth Quarter 2017 Earnings Conference Call And Webcast September 28, 2017
Arbutus' LNP Licensee Alnylam Initiates Rolling Submission of NDA to U.S. FDA for Patisiran November 16, 2017
Achillion Slashes Staff and Initiates Restructuring Following Termination of J&J Deal February 21, 2018
